Characterization of the immune checkpoint inhibitor response in the MC38 murine colon cancer model

被引：0
|
作者：
Fadden, Patrick [1 ]
Bui, Thi [1 ]
Hurtado, David [1 ]
Davis, Kelli [1 ]
Belle, Ian [1 ]
Krontz, Kathrine [1 ]
Hauser, Jacob [1 ]
Li, Na [2 ]
Takayama, Kyle [2 ]
Sokolowski, Cristina [1 ]
Wood, Edgar [1 ]
机构：
[1] Charles River Labs, Morrisville, NC USA
[2] Charles River Labs, Durham, NC USA
来源：
CANCER RESEARCH | 2019年 / 79卷 / 13期
关键词：
D O I：
10.1158/1538-7445.AM2019-LB-060
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-060
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Combination Therapy of Mithramycin A and Immune Checkpoint Inhibitor for the Treatment of Colorectal Cancer in an Orthotopic Murine Model
    Dutta, Rinku
    Khalil, Roukiah
    Mayilsamy, Karthick
    Green, Ryan
    Howell, Mark
    Bharadwaj, Srinivas
    Mohapatra, Shyam S.
    Mohapatra, Subhra
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [22] Multiplex digital spatial profiling of proteins and RNA in MC38 mouse colorectal cancer syngeneic model
    Chen, Meihui
    Liu, Hengyuan
    Tu, Xiaolong
    Guo, Sheng
    Chen, Xiaobo
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Immune Checkpoint Inhibitors (ICI) Enhance Cancer Associated Thrombosis (CAT) in Murine Model of Colon Carcinoma
    Swaidani, Shadi
    Shim, Young Jun
    Rayman, Patricia
    Pavicic, Paul G.
    Diaz-Montero, C. Marcela
    Khorana, Alok A.
    McCrae, Keith R.
    BLOOD, 2021, 138
  • [24] Loss of tumorigenicity of murine colon carcinoma MC38/0 cell line after transduction with a retroviral vector carrying murine IL-12 genes
    Pajtasz-Piasecka, E
    Szyda, A
    Rossowska, J
    Krawczenko, A
    Indrová, A
    Grabarczyk, P
    Wysocki, P
    Mackiewicz, A
    Dus, D
    FOLIA BIOLOGICA, 2004, 50 (01) : 7 - 14
  • [25] Obesity Strongly Promotes Growth of Mouse MC38 Colon Cancer in an Orthotopic-syngeneic C57BL/6 Mouse Model
    Hamada, Kazuyuki
    Kubota, Yutaro
    Aoki, Yusuke
    Sugisawa, Norihiko
    Yamamoto, Jun
    Tashiro, Yoshihiko
    Bouvet, Michael
    Tsunoda, Takuya
    Hoffman, Robert M.
    IN VIVO, 2022, 36 (04): : 1643 - 1646
  • [26] Predictive biomarkers for immune checkpoint inhibitor response in urothelial cancer
    Parent, Pauline
    Marcq, Gautier
    Adeleke, Sola
    Turpin, Anthony
    Boussios, Stergios
    Rassy, Elie
    Penel, Nicolas
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2023, 15
  • [27] Impact of cancer evolution on immune surveillance and checkpoint inhibitor response
    Wu, Yin
    Biswas, Dhruva
    Swanton, Charles
    SEMINARS IN CANCER BIOLOGY, 2022, 84 : 89 - 102
  • [28] Combined therapy with methotrexate nanoconjugate and dendritic cells with downregulated IL-10R expression modulates the tumor microenvironment and enhances the systemic anti-tumor immune response in MC38 murine colon carcinoma
    Szczygiel, Agnieszka
    Wegierek-Ciura, Katarzyna
    Wroblewska, Anna
    Mierzejewska, Jagoda
    Rossowska, Joanna
    Szermer-Olearnik, Bozena
    Switalska, Marta
    Anger-Gora, Natalia
    Goszczynski, Tomasz M.
    Pajtasz-Piasecka, Elzbieta
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [29] Are the syngeneic mouse Colorectal Cancer models MC38 and CT26 representative of human microsatellite instable and microsatellite stable Colon Cancer?
    Fofanah, I. J.
    JOURNAL OF PATHOLOGY, 2024, 264 : S13 - S13
  • [30] Mefformin inhibits in vivo growth of MC38 colon carcinoma in the absence of LKB1 expression
    Algire, Carolyn
    Amrein, Lilian
    Bazile, Miguel
    Zakikhani, Mahvash
    David, Stephanie
    Pollak, Michael
    CANCER RESEARCH, 2010, 70
12345